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1. INTRODUCTION 
Cancer is a disease characterized by uncontrolled multiplication and spread of 
abnormal form of the body’s own cells. It is one of the major causes of death in the 
developed Nations. Cancer is also responsible for approximately one quarter of all 
death in the world with lung and bowel cancer comprising the largest category closely 
followed by breast and prostate cancer (1). 
TYPES OF CANCER (2-3) 
Cancer is classified in two ways: by the type of tissue in which the cancer 
originates (histological types) and by primary site, or the location in the body where 
the cancer first developed.  
Carcinoma 
Cancers derived from epithelial cells. This group includes the most common 
cancers, particularly in the aged and include nearly all those developing in 
the breast, prostate, lung, pancreas and colon. 
Sarcoma 
Cancer arising from connective tissues (i.e. bone, cartilage, nerve), each of 
which develops from cells originating in mesenchymal cells outside the bone marrow. 
Lymphoma and leukemia 
These two classes of cancer arise from hematopoietic (blood-forming) cells 
that leave the marrow and tend to mature in the lymph nodes and blood respectively. 
Leukemia is the most common type of cancer in children accounting for about 30%. 
Germ cell tumor  
Cancer derived from pluripotent cells, most often presenting in the testicle or 
the ovary (seminoma and dysgerminoma respectively). 
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Blastoma 
Cancers derived from immature "precursor" cells or embryonic tissue. 
Blastomas are more common in children than in adults. 
 
 
Fig. 1 Cancer cell proliferation 
 
 
SINGS AND SYMPTOMS  
The signs and symptoms of cancer will depend on where the cancer is, how 
big it is, and how much it affects the organs or tissues. If a cancer has spread 
(metastasized), signs or symptoms may appear in different parts of the body (4). 
As cancer grows, it can begin to push on nearby organs, blood vessels and 
nerves. This pressure causes some of the signs and symptoms of cancer. If the cancer 
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is in a critical area, such as certain parts of the brain, even the smallest tumor can 
cause symptoms. 
But sometimes cancer starts in places where it won’t cause any signs or 
symptoms until it has grown quite large. Cancers of the pancreas, for example, usually 
don’t cause symptoms until they grow large enough to press on nearby nerves or 
organs (this causes back or belly pain). Others may grow around the bile duct and 
block the flow of bile. This causes the eyes and skin to look yellow (jaundice). By the 
time a pancreatic cancer causes signs or symptoms like these, it’s usually in an 
advanced stage. This means it has grown and spread beyond the place it started – the 
pancreas(5). 
A cancer may also cause symptoms like fever, extreme tiredness (fatigue), or 
weight loss. This may be because cancer cells use up much of the body’s energy 
supply, or they may release substances that change the way the body makes energy 
from food. Cancer can also cause the immune system to react in ways that produce 
these signs and symptoms. 
Sometimes, cancer cells release substances into the bloodstream that cause 
symptoms that are not usually linked to cancer. For example, some cancers of the 
pancreas can release substances that cause blood clots in veins of the legs. Some lung 
cancers make hormone-like substances that raise blood calcium levels. This affects 
nerves and muscles, making the person feel weak and dizzy(6). 
Typical symptoms of cancer includes (7)  
  Presence of an unusual lump in the body  
 Changes in a mole on the skin 
 A persistent cough or hoarseness  
 A change in bowel habits, such as unusual diarrhoea or constipation 
 Difficulty in swallowing or continuous indigestion 
 Any abnormal bleeding, including bleeding from the vagina 
or blood in urine or faeces 
 A persistent sore or ulcer 
 Difficulty in passing urine 
 Unexplained weight loss 
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 Unexplained pain 
 Unexplained tiredness or fatigue 
 Skin changes such as an unexplained rash or unusual texture 
 Unexplained night sweats 
 Abdominal pain 
PARTS AFFECTED 
Cancer affects various parts of the body like brain, liver, bladder, thyroid, 
skin, pancreas, bone, lung, kidney, brain, cervical, lymphoma etc., 
TYPES OF TREATMENTS  
The aim of cancer treatment is to cure the cancer. In some cancers that are 
very slow-growing or that have spread beyond the original area of the body, the aim 
may be to control the cancer and delay its progress. 
The main treatments for cancer are surgery, radiotherapy and chemotherapy. 
Other treatments, such as hormonal therapy and targeted therapy may also be used for 
certain cancers. Often, a combination of more than one type of treatment is used. 
 
Fig.2 Cancer and the human body: An inside look 
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Surgery 
Surgery aims to remove all or part of a tumor. Some operations are done as 
day surgery, so the person only needs to take a short time off work. Others are more 
complex and spending a few weeks, or even months away from work.  
Radiotherapy 
This treatment uses high-energy x-rays to destroy cancer cells, while doing as 
little harm as possible to normal cells. Radiotherapy that aims to cure the cancer will 
often mean a person needs to go to the hospital for several weeks (8, 9).  
Chemotherapy 
Chemotherapy drugs interfere with the process of cell division. They affect 
normal cells as well as cancer cells. As a result, they often cause side effects. The 
drugs are often given as a liquid through a drip into a vein (intravenously). They 
circulate in the blood stream and reach the cancer cells wherever they are in the body. 
Some chemotherapy drugs are given as tablets or capsules, which can be taken at 
home. 
Intravenous chemotherapy may take minutes, hours or a few days. The 
treatment is followed by a few weeks of rest to allow the body to recover from any 
side effects. Together, the treatment and the rest period are known as a cycle of 
chemotherapy. Usually 4–6 cycles of treatment are given, which take 4–8 months(10). 
Some treatments for particular types of cancer last much longer than this, while others 
may be shorter. Sometimes, a drug is given continuously into the vein by a small 
portable pump over the course of a few months. 
Hormonal therapies 
These are drugs that can stop or slow the growth of cancer cells by either 
changing the level of particular hormones in the body, or preventing hormones 
affecting the cancer cells. Most hormonal therapies are given as tablets, but some are 
given as injections every few weeks or months and they do still have side effects. 
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Targeted therapies 
These are part of a newer group of drug treatment that works by targeting the 
growth of cancer cells. They generally have little effect on normal cell growth, so they 
usually have less troublesome side effects than chemotherapy. Targeted therapies may 
be given as a drip (intravenous infusion) or as tablets. Tiredness and other side effects 
may sometimes make this difficult (11). 
DISADVANTAGES OF CANCER TREATMENTS 
Side effects and how long they last will depend on the treatment being given 
and also vary from person to person. Some people will be able to work during their 
treatment, while others will need to be off for a few weeks or months. Common side 
effects of treatments include fatigue, risk of infection, nausea (feeling sick), vomiting 
(being sick), hair loss, sore mouth, diarrhoea or constipation, numbness or tingling in 
the hands or feet and body changes.  
Cancer and its treatments can cause physical changes. These may be 
temporary or permanent.  Body changes depends on the individual’s situation, but 
other changes includes; Hair loss, changes in complexion or skin tone, altered 
appearance after surgery, weight loss or gain. Tiredness for many months or 
sometimes years, pain or lack of movement in an arm after breast surgery and can 
able to eat little and often after stomach surgery. 
 
Disadvantages of Radiotherapy and chemotherapy  
Radiotherapy not only destroys the cancer cells but it damages the normal 
cells also which is the major side effect of this therapy. In case of pregnancy 
radiotherapy may injure the fetus. Radiotherapy equipment is expensive so the 
treatment is also highly expensive. 
Lowered a WBC, RB and Platelet count which increases the risk of infection, 
anemia, bleeding and bruising.  Damage to the nerve system that may further weaken 
a person mental capacity, increased  memory loss and cause fatigue(12). 
It is well recognized that allopathic drugs are not without danger as they 
produce side effect to the normal cell and the chemotherapeutic agents causes non 
selective damage to the normal cell, therefore worldwide research is now focusing on 
the investigation of best antitumor agents from herbal sources. 
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HERBAL DRUGS IN THE TREATMENT OF CANCER (13-16) 
 
Plant and herbs used in the folk and traditional medicine have been accepted 
currently as one of the main source of chemoprevention drug discovery and 
development(13).  Around 60% of currently used anticancer agents are derived in one-
way or another from natural sources, including plants, marine source and micro 
organisms. 
Herbal medicines are plant derived materials or preparations, which contain 
raw or processed ingredient from one or more plants with therapeutic value and used 
as dietary supplements to fight or prevent common diseases in various systems of 
medicine such as Ayurveda, Unani and Siddha. Plant products have been used 
throughout human history for various purposes including medicine(14). Herbs can be 
viewed as biosynthetic chemical laboratories, producing a number of chemical 
compounds. Herbal drugs ranges from parts of plants to isolated purified active 
constituents. They may come from mostly leaves, roots, barks, seeds and flower. They 
are eaten, swallowed, drunk, inhaled or applied to the skin. Several secondary 
metabolites are produced by the higher plants as natural defense against disease and 
infections. The Indian system of medicine known as Ayurveda uses mainly plant 
based drug or formulation to treat various disease including cancer: and around. 
Approximately 877 small molecule drugs are introduced worldwide between 1981- 
2002, 61% can be traced back to their origin in natural products. Recent surveys 
suggest that one in three persons use medicinal natural products daily and possibly 
one in two cancer patients use them as well. 
A brief review on Japanese anticancer plants proves that various phyto 
constituents viz., terpenoids, saponins, polyphenols, polysaccharide, flavonoids, 
glycoside, alkaloids have been reported to inhibit tumor. In recent years, extensive 
research has been focused on the anticarcinogenic potential of triterpenes, flavonoids 
and  polyphenols(15, 16). 
 
 
Introduction 
 
Department of Pharmacognosy, MMC. Page 8 
 
 
Table 1. Few plants which are likely to possess anticancer activity are listed below 
S.NO BOTANICAL 
SOURCE 
PARTS 
USED 
CONSTITUNTION USE 
1 Abrus precatorious Seeds Abrin, Lectin Suppress DLA and 
EAC 
2 Catharanthus 
roseus 
Herbs Alkaloids-
Vincristine, 
 Vinblastin 
Leukemia, lymphoma,  
lung and breast cancer 
3 Camptotheca 
acuminata 
Herbs Camptothecin Colorectal, ovarian 
and  
lungs cancer 
4 Plumbago rosea Herbs Napthoquinones-   
Plumbagin 
EAC 
5 Taxus brevifolia Bark Taxol Lung, breast and neck 
cancer 
6 Cissus 
quadrangularis 
Climber Triterpenoids Tumor 
   
Although many plants are used to treat tumors in Indian traditional systems of 
medicine, most of these plants are not scientifically evaluated. If a systemic and 
intensive ethno pharmacological study is carried on one or more plants used in 
traditional system, are sure to provide effective anticancer drugs. In view of the wide 
spread interest on Asparagus the present work has been undertaken for the 
investigation of anticancer activity of the leaves of Asparagus recemosus Willd., 
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2. REVIEW OF LITERATURE 
The literature review encompasses the systematic information on pharmacognosy, 
phytochemistry and pharmacological studies of the leaves of Asparagus racemosus 
Willd., It was found that very little information was available on the leaves of this 
species. 
PHARMACOGNOSTICAL REVIEW 
 No pharmacognostical work has been done on the leaves. 
PHYTOCHEMICAL REVIEW 
 Verma A et al., (2014) studied the isolation, purification and spectral analysis 
of pure compound obtained from leaf extract of Asparagus racemosus (17). 
 Shashi Alok et al., (2013) conducted a study in plant profile, phytochemistry 
and pharmacology of Asparagus racemosus (Shatavari)(18).  
 Asha Verma and N.Singh (2012) studied the chromatographic separation of 
ethyl acetate crude extract of Shatavari : A ethnomedicinal plant(19)
.
 
 V.K.Karmakar et al., (2012) carried out the phytochemical investigation and 
antibacterial and antioxidant potentials of Asparagus racemosus (20). 
 
PHARMACOLOGICAL REVIEW 
 
 Shiv Prakah Varma et al., (2014) studied the inhibitory effects of Asparagus 
racemosus leaf extract on renal cell carcinoma cell line(21) . 
 Battu GR and Kumar BM (2013) conducted a study in anti-inflammatory 
activity of leaf extract Asparagus racemosus Willd. (22).  
 Asha Verma et al., (2013) investigated invitro antioxidant activity and 
phytochemical screening of ethyl acetate extract of leaves of Asparagus 
racemosus
(23)
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3. PLANT PROFILE 
 
Fig. 3 Asparagus racemosus Willd., 
PLANT PROFILE (24-29) 
Botanical name          : Asparagus racemosus Willd., 
Common name           : Satavari  
Tamil name                : Thannirvitan Kelangu, Ammaikodi                                 
Family                        : Liliaceae 
TAXONOMICAL STATUS 
                       Kingdom                   : Plantae- plant 
                       Division                     : Magnoliophyta- flowering plant 
                       Class                           : Liliopsida- monocotylendons   
                       Order                          : Liliaces  
                       Family                       : Liliaceae 
                                   Genus                         : Asparagus                          
                                   Species                       : racemosus  
Plant Profile 
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Plant decription  
 Asparagus racemosus Willd., is a perennial shrub, with a tuberous root-stock, 
stems covered with recurved spines, linear leaves arranged in a tuft, white flowers and 
sweet-scented appears in October. 
Habitate  
It grows in a variety of habitats including open forest found wild in tropical 
and subtropical parts of India including the Andamans and ascending in the 
Himalayas to 1500 meter.  
Ethnomedicinal uses  
Used in the treatment of rheumatism, cough, fertility problem, dysentery, 
diarrhoea, gastric complaints, gonorrhea, leucorrhoea, impotency, stomach problem, 
dyspepsia, anemia, general debility, typhoid, retention of urine, tonic, fever, gout and 
used to increase lactation, sperm count and tonic. The paste of fresh leaves is used on 
the burning sensation of the skin in smallpox. 
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4. RATIONALE FOR SELECTION OF THE PLANT 
Now a day’s lots of herbal plants are being upgraded by validating the 
traditional claims and establishing its medicinal value. Various plants are yet to be 
scientifically proven for their therapeutic efficacy. Asparagus racemosus Willd., is 
one such plant belonging to the family Liliacea. This plant is commonly known as 
Satavari. 
 The plant has a long history of numerous traditional and ethno botanical 
applications in diverse cultures. Asparagus racemosus Willd., (Liliaceae) is 
traditionally used in the treatment of   dysentery, epilepsy, inflammation, leprosy, 
night blindness, tuberculosis, snake bite, cancer,  spasms, gonorrhea, piles, diabetes, 
rheumatism,  cough, diarrhoea, gastric troubles, head ache  and it increases the 
lactation. The aerial parts are used as spasmolytic, anticancer, anti arrhythmic, 
antibacterial and anti fungal (30-32). Traditionally the aerial part has been used for the 
treatment of cancer but there is no scientific proof. So, the present study was 
undertaken to investigate the effects of Asparagus racemosus Willd., leaves on 
anticancer activity.  
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5. AIM AND OBJECTIVES 
AIM 
The main aim of the present work is to study the anticancer activity of the 
leaves of Asparagus racemosus Willd.,  
The main objectives of the present study are 
o To standardize the leaves of Asparagus racemosus Willd., by carrying 
out the pharmacognostical and phytochemical studies. 
o To evaluate the  invitro anticancer activity of various extracts  
o To evaluate the invivo anticancer activity  
o Isolation and identification  of  Rutin  
Plan of Work 
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6. PLAN OF WORK 
 
1. Collection of  the plant material 
2. Authentication 
 
3. PHARMACOGNOSTICAL STUDIES 
 Macroscopy 
 Microscopy 
 Physicochemical constants 
 Qualitative analysis of heavy metals and inorganic 
elements 
 Quantitative estimation of heavy metals  
 Pesticide residue analysis  
 
4.  PHYTOCHEMICAL STUDIES 
 Preparation of extracts 
 Preliminary phytochemical screening and fluorescence 
analysis of powder and extracts 
 Quantitative estimation of phytoconstituents 
 Thin layer chromatography of extracts 
 High Performance Thin Layer Chromatography 
 
5. SELECTION OF ACTIVE EXTRACT   
Invitro anticancer activity by MTT Assay 
6. ACUTE TOXICITY STUDIES 
7. INVIVO ANTICANCER ACTIVITY  
8. ISOLATION AND IDENTIFICATION OF RUTIN  
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7. PHARMACOGNOSTICAL STUDIES (33, 34) 
Pharmacognostical studies basically deals with the identification, 
authentication and standardization of herbal medicinal plants through macroscopical, 
microscopical characters and physicochemical observations as prescribed by an 
authoritative source such as World Health Organization (WHO). This should be 
carried out before any tests are undertaken, because lack of proper identification leads 
to the usage of improper drug. Thus, in recent years there has been an emphasis in 
pharmacognostical standardization of medicinal plant of therapeutic potential which 
will help in the correct identification of the plant. 
7.1 MATERIALS AND METHODS 
Collection and authentication of the plant  
The fresh and healthy leaves of Asparagus racemosus Willd., were collected 
from Ariyaperumbakkam Village, Kanchipuram Dist., Tamil Nadu, India during the 
month of August 2014.  The plant was identified and authenticated by Dr. Jayaraman, 
Director, Plant Anatomy and Research Centre, Thambaram (PARC/2014/2316).  A 
voucher specimen has been reserved in the Department of Pharmacognosy, COP, 
MMC, Chennai. The leaves were immediately fixed using FAA (formalin: acetic acid: 
ethyl alcohol) as fixative agent for anatomical studies. 
 
Macroscopy  
 Macroscopical characters include organoleptic characters and morphological 
features of the leaves were studied.  
Microscopical studies (35-38) 
Staining method 
 The collected leaves were fixed in FAA solution (formalin-5ml+ Acetic acid-
5ml + 70% Ethyl alcohol-90ml). After 24 hrs of fixing, it was dehydrated with graded 
series of tertiary butyl alcohol as per the schedule given by Sass 1940. Infiltration of 
the leaves was carried by gradual addition of paraffin wax (melting point 58-60o C) 
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until TBA solution attained super saturation. The leaves were cast into paraffin 
blocks. 
Sectioning (39, 40) 
The paraffin embedded leaves were sectioned with the help of Rotary 
Microtome. The thicknesses of the sections were 10-12µm. The sections were stained 
with Toluidine blue. Since, toluidine blue is a polychromatic stain different colours of 
the cells were obtained depending upon the nature of the cells.  
Photomicrographs  
Microscopic descriptions of tissues are supplemented with micrographs 
wherever necessary. Photographs of different magnifications were taken with Nikon 
lab photo 2 microscopic unit. For normal observations bright field was used. For the 
study of crystals, starch grains and lignified cells, polarized light was employed. Since 
these structures have birefringent property, under polarized light they appear bright 
against dark background. Magnifications of the figures are indicated by the scale-bars. 
Descriptive terms of the anatomical features are as given in the standard Anatomy 
books. 
Powder microscopy (41, 42) 
  The shade dried, powdered leaves were used for powder microscopic 
analysis. The organoleptic characters were observed and to identify the different 
characteristic features, staining reagents were used. Powder was stained with 1% 
phloroglucinol in conc. hydrochloric acid and observed under microscope. All the 
lignified cells stained with pink colour.  
Physicochemical constants (43-45)  
                Shade dried powdered leaves of Asparagus racemosus  was used for the 
determination of physicochemical constants in accordance with WHO guidelines. 
Ash values 
                 Ash values are helpful in determining the quality and purity of a crude drug 
in the powdered form. The residue remaining after incineration is the ash content of 
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the drug, which simply represents inorganic salts, naturally occurring to the drug or 
adhering to it or deliberately added to it, as a form of adulteration. 
Total ash  
                Total ash is designed to measure the total amount of ash remaining after 
incineration. This includes both physiological ash which is derived from plant tissue 
itself and non-physiological ash which is the residue of the extraneous matter 
adhering to the plant surface. 
Procedure  
Silica crucible was heated to red hot for 30min and it was allowed to cool in a 
desiccator. About 2gm of powder was taken in to the silica crucible and it was ignited 
at a temperature not exceeding 600oC until free carbon, cooled in a desiccator for 
30min and weighed. The percentage of ash was calculated with reference to the air 
dried drug. 
Water soluble ash 
The total ash was boiled with 25ml of water for 5min. The insoluble matter 
was collected in an ashless filter paper, washed with hot water and ignited for 15min 
at a temperature not exceeding 450oC, cooled and weighed. The percentage of water 
soluble ash was calculated with reference to air dried drug. 
Acid insoluble ash  
Acid insoluble ash is the residue obtained after boiling the total ash with dilute 
hydrochloric acid and igniting the remaining insoluble matter. This measures the 
amount of silica present, especially as sand and siliceous earth. 
Procedure  
To the total ash 25ml of dil.HCl was added drop wise and ignited. The 
insoluble matter was collected in an ashless filter paper and washed with hot water 
until the filtrate is neutral. The insoluble matter was transferred into a crucible. The 
residue was cooled in a desiccator for 30min and weighed. The content of acid 
insoluble ash was calculated with reference to air dried drug. 
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Sulphated ash 
Procedure 
 Silica crucible was heated to red hot for 30min and it was allowed to cool in 
desiccator. 2gm of substance was taken into the crucible, ignited gently at first until 
the substance is thoroughly charred. Cooled and the residue was moistened with 1ml 
of sulphuric acid, heated gently until fumes are no longer evolved. Ignited at 
800±25oC until all black particles disappeared. Cooled the crucible and few drops of 
sulphuric acid was added and heated again. The operation is repeated until two 
successive weighing do not differ by more than 0.5gm. 
Determination of extractive values 
Extractive values are useful for the evaluation of phytoconstituents especially 
when the constituents of a drug cannot be readily estimated by any other means. 
Further these values indicate the nature of the active constituents present in a crude 
drug. 
Determination of water soluble extractive  
5gm of the leaf powder was weighed and macerated with 100ml of chloroform 
water (95ml distilled water and 5ml chloroform) in a closed flask for 24 hours. It was 
shaken frequently for six hours and allowed to stand for eighteen hours. It was then 
filtered rapidly, taking precautions against loss of solvent and 25ml of the filtrate was 
evaporated to dryness in a tarred flat bottomed shallow dish. The percentage of water 
soluble extractive value with reference to the air dried drug was calculated. 
Water soluble extractive value = weight of the dried extract / weight of the 
sample taken × 100 
Determination of alcohol soluble extractive 
5gm of the powder was weighed and macerated with 100ml 90% ethanol in a 
closed flask for 24 hours. It was shaken frequently for six hours and allowed to stand 
for eighteen hours. It was then filtered rapidly, taking precautions against loss of 
solvent and 25ml of the filtrate was evaporated to dryness in a tarred flat bottomed 
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shallow dish. It was dried at 105°C for 1hour in a hot air oven. The dish was cooled in 
desiccator and weighed. The process was repeated till the constant weight was 
obtained. The percentage of alcohol soluble extractive value with reference to the air 
dried drug was calculated. 
Alcohol soluble extractive = weight of the dried extract / weight of the sample taken × 
100 
Determination of non volatile ether soluble extractive (fixed oil content) 
A suitably weighed quantity of the drug was transferred to an extraction 
thimble and extracted with petroleum ether (Boiling Point 40 - 60°C) in a Soxhlet 
apparatus for 6 hours. The extract was filtered into a tarred evaporating dish, 
evaporated and dried at 105°C to constant weight. The percentage of non volatile 
ether soluble extractive value with reference to the air dried drug was calculated. 
Determination of volatile ether soluble extractive 
2gm of powdered drug was accurately weighed and extracted with anhydrous 
diethyl ether in a continuous extraction apparatus for 20hours. The ether solution was 
transferred to tarred porcelain dish and evaporated spontaneously. Then it was dried 
over phosphorous pentoxide for 18hrs and the total ether extract was weighed. The 
extract was heated gradually and dried at 105°C to constant weight. The loss in 
weight represents the volatile portion of the extract. 
Loss on drying (46) 
Specified quantity of the substances was taken in a previously ignited and 
cooled silica crucible and the substance was evenly distributed by gentle side wise 
shaking. The crucible with the contents and the lid were weighed accurately. The 
loaded crucible and the lid were placed in the drying chamber (105°C). The substance 
was heated for a specified period of time to a constant weight. The crucible was 
covered with the lid and allowed to cool in a dessicator at room temperature before 
weighing. Finally the crucible was weighed to calculate the loss on drying with 
reference to the air dried substance.   
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Determination of foaming index  
1gm of the coarsely powdered drug was weighed and transferred to 500ml 
conical flask containing 100ml boiling water. The flask was maintained at a 
temperature of 80-90°C for about 30min. It was then cooled and filtered into a 
volumetric flask and sufficient water was added through the filtrate to make up the 
volume to 100ml. The decoction was poured into 10 stopper test tubes (height 16cm, 
diameter 16mm) in successive portions of 1ml, 2ml, 3ml, 4ml up to 10ml and the 
volume of the liquid in each tube was adjusted with water to 10ml. The tubes were 
stoppered and shaken in a length wise motion for 15 seconds, two shakes per second. 
They were allowed to stand for 15min and the height of the foam was measured. The 
results were assessed as follows: If the height of the foam in every tube is less than 
1cm, the foaming index is less than   100. If a height of 1cm is measured in any tube, 
the volume of the plant material decoction in the tube (a) is used to determine the 
index. If this tube is the first or second tube in a series, prepare an intermediate 
dilution in a similar manner to obtain a more precise result. 
If the height of the foam is more than 1cm in every tube, the foaming index is 
over 1000. In this case repeat the determination using a new series of dilution of the 
decoction in order to obtain a result. Calculate the foaming index using the following 
formula. 
                                      Foaming index = 1000/a 
Where, a = the volume in ml of the decoction used for preparing the dilution in the 
tube where foaming to a height of 1cm is observed. 
Determination of swelling index (47) 
 The swelling index is the volume in ml occupied by the swelling of 1gm of 
plant material under specified conditions. A specified quantity of the plant material  
previously reduced to the required fineness was accurately weighed and transferred 
into a 25ml glass stoppered measuring cylinder. The internal diameter of the cylinder 
should be about 16mm, the length of the graduated portion about 125mm, marked in 
0.2ml divisions from 0 to 25ml in an upward direction. 25ml of water was added and s 
the mixture was shaken thoroughly every 10min for 1hour, allowed to stand for 3 
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hours at room temperature. The volume in ml occupied by the plant material was 
measured including any sticky mucilage. The mean value of the individual 
determination, related to 1gm of plant material was calculated. 
Foreign organic matter 
100g of the drug sample was weighed and spread out as a thin layer. The 
foreign matter was detected by inspection with the use of a lens. Foreign matter found 
were separated and weighed and the percentage was calculated.  
      Foreign organic matter = Weight of the sample after inspection  
                                               Weight of the sample before inspection 
Crude fiber content (48) 
About 2g of the accurately weighed drug sample was extracted with ether. 
Then 200ml of 1.25% sulphuric acid was added to the extracted drug and the whole 
mixture was boiled for 30mins under reflux in a 500ml flask. The whole mixture was 
then filtered through a hardened filter and the residue was washed with boiling water 
until free of acid. The entire residue was rinsed back into the flask with 200ml boiling 
1.25% sodium hydroxide solution and again boiled under reflux for 30mins. The 
liquid was then quickly filtered through a tarred filter and the residue on the filter was 
washed with boiling water until neutral, dried at 1100C to constant weight. The 
difference between the weight of the dried residue and that of the incinerated residue 
represents the weight of the crude fibre and expressed as percentage of the original 
weight of the material. 
ESTIMATION OF HEAVY METALS AND INORGANIC ELEMENTS (49) 
                         Plant minerals play a vital role in metabolism and osmolity. Presence 
of elements vary with the soil, climate conditions etc. There are essential and non 
essential elements which may be beneficial or harmful to living things. Non essential 
elements like lead, arsenic, cyanide, chromium, cadmium, aluminium, silver bring 
about toxic effects resulting in intoxification. Hence, qualitative estimation of 
inorganic elements in the powdered leaves of Asparagus racemosus Willd. were 
carried out. 
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QUALITATIVE ANALYSIS OF INORGANIC ELEMENTS AND HEAVY 
METALS 
To the ash of the drug material 50%v/v hydrochloric acid was added and kept 
for 1 hour. It was filtered and the filtrate was used for the following tests. 
Aluminium: White gelatinous precipitate of aluminium hydroxide is formed on 
addition of ammonia solution. It is slightly soluble in excess of the reagent. The 
precipitate dissolves readily in strong acid and base, but after boiling it becomes 
insoluble.   
Arsenic:  Arsenous salts in neutral solution react with solution of copper sulphate to 
form green precipitate (Scheele’s green) which on boiling gives a red precipitate of 
cupric oxide. 
Borate: The mixture obtained by the addition of sulpuric acid and alcohol (95%) to a 
borate when ignited, burns with flame tinged with green. 
Calcium: Solution of calcium salts, when treated with ammonium carbonate solution, 
yield a white precipitate after boiling and cooling the mixture (it is insoluble in 
ammonium chloride solution). 
Carbonate: Carbonate, when treated with dilute acid, effervescence liberating carbon 
dioxide which is colourless and produces a white precipitate in calcium hydroxide 
solution. 
Chlorides: Chlorides, when treated with silver nitrate solution, yield a white crude 
precipitate which is insoluble in nitric acid, but soluble after being well washed with 
water, in diluted ammonia, from which it is re precipitated by the addition of nitric 
acid. 
Copper: An excess of ammonia, added to a solution of a cupric salt, produces first a 
bluish precipitate and then a deep blue coloured solution. 
Iron: Solution of ferric salts, when treated with potassium ferrocyanide solution, 
yields an intense blue precipitate which is insoluble in dilute HCl. 
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Lead: Strong solution of lead salts, when treated with HCl, yield a white precipitate 
which is soluble in boiling water and is deposited as crystals when the solution is 
cooled. 
Magnesium: Solution of magnesium salts, when treated with ammonium carbonate 
solution and boiled, yield a white precipitate, but yield no precipitate in the presence 
of ammonium chloride solution. 
Mercury: Solution of mercury salts, when treated with sodium hydroxide solution, 
yields a yellow precipitate. 
Nitrate: With solution of ferrous sulphate no brown colour was observed but if 
sulphuric acid is added (slow from the side of the test tube), a brown colour is 
produced at the junction of two liquids, indicating the presence of nitrates. 
Phosphate: Solution of phosphate when treated with silver nitrate, dilute ammonia 
solution and in dilute nitric acid yield yellow precipitate of normal silver ortho 
phosphate (distinction from meta and pyrophosphate) solution. 
Potassium: Moderately strong potassium salts, which have been previously ignited to 
remove ammonium salts, when treated with perchloric acid (60%) yield a white 
crystalline precipitate. 
Silver: Solution of silver salts, when treated with potassium iodide solution yield a 
cream coloured precipitate which is insoluble in dilute ammonia solution and in nitric 
acid. 
Sulphates: Solution of sulphates, when treated with lead acetate solution yields a 
white precipitate which is insoluble in ammonium acetate solution and in sodium 
hydroxide. 
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QUANTITATIVE ANALYSIS OF HEAVY METALS (50) 
 The heavy metals are quantitatively determined by using Inductive coupled 
plasma-Optical emission spectroscopy. 
Instrumentation parameters:  
Instrument name: Inductive coupled plasma-Optical emission spectroscopy. 
Instrument Model: PE Optima 5300DV ICP-OES; Optical system Dual 
view-axial or radial. 
Detector system: Charge coupled detector, (UV-Visible detector which is 
maintaining at -40º C) to detect the intensity of the emission line. 
Light source (Torch): Positioned horizontally in the sample compartment 
along the central axis of the spectrometer optics. Changing from axial to radial 
viewing is a simple software command and is accomplished by computer control of a 
mirror located in the optical path. The torch assembly of this system comprises of two 
concentric quartz tubes. 
Standard alumina injector: 2.0mm inner diameter.  
Spray chamber: Scott type 
Nebulizer: Cross flow gem tip. 
Preparation of sample by acid digestion method: 
   50mg of powder was treated with acid mixture of sulphuric acid: water in the 
ratio of 4:1in the Kjeldahl flask and heated continuously till the solution is colourless. 
The sample mixture was then transferred in a 25ml volumetric flask and made up to 
the volume with distilled water. Blank solution was prepared as above without 
sample. 
            The standards of arsenic, lead, mercury and cadmium were prepared as per the 
protocol and the calibration curve was developed for each of them. 
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PESTCIDE RESIDUE ANALYSIS (BY GC-MS) (51, 52) 
Medicinal plant materials may contain pesticide residues, which accumulate as 
a result of agriculture practices such as spraying, treatment during cultivation and 
administration of fumigants during storage. Furthermore, similar to other agriculture 
products, there could be contamination from microorganism, heavy metal and 
pesticides. The contamination of medicinal plants by pesticides may be a consequence 
of the use of pesticides during cultivation, migration from neighboring culture or due 
environmental contamination. 
Since many medicinal preparation of plant origin are taken over long periods 
of time, limits for pesticide residues should be established, following recommendation 
of the food and agriculture organization (FAO) of the United Nation and World 
Health Organization (WHO) which have already established the safety index of these 
residues in food and animal feed. This guideline includes the analytical methodology 
of pesticide residues. 
Out of various pesticides available only chlorinated hydrocarbon and related 
pesticides like aldrin, BHC, chlordane, dieldrin, DDT and few organo-phosphorous 
pesticides like carbophenothion retain a long residual action. 
Chromatography (column and GC) is the principle method for the 
determination of pesticides residue. Samples are extracted by standard procedures, 
impurities are removed by partition or adsorption and moderately broad spectrum of 
pesticides are measured in single determination. 
Instrument parameters and conditions 
Instrument                 Gas chromatography with mass spectroscopy 
Make and Model   Hewlett Packard 
Specification              Electron ionization source with Quadra pole analyzer 
Mass range                10-425 atmosphere  
Detector                     Electron ionization detector 
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Procedure  
Extraction of the pesticides from the solid sample was carried out by solvent 
extraction. About 2.0g of the powder was treated with 15ml of n-hexane: 
dichloromethane (4:1). Sample was blended for 3mins and  the solution mixture was 
transferred to 50ml tubes and centrifuged for 12mins. The supernatant was 
concentrated at 40oC to a volume approximately to 1ml.  The cleanup of the extract 
was carried out by solid- phase extraction on a column packed with silica gel. The 
column was conditioned with 6ml dichloromethane and not allowed to dry. The 
extract (1ml) was applied to the column and eluted with 45ml of n-hexane: 
dichloromethane (3:2 v/v). The elute was concentrated almost to dryness and diluted 
with n-hexane to a volume of 1.0ml. 1µl volume was injected automatically into the 
GC-MS. 
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7.2 RESULTS AND DISCUSSION  
MACROSCOPY 
The leaves (cladodes) are like pine needles, small and uniform and flowers are 
white and have small spikes.  
Leaf blade         - triangular in transverse section 
Margin               -not visible. 
Taste                  -Sweet and bitter. 
Colour               - Dark green 
Size                   -1-5mm long  
Shape                -Pine needles (phylloclade’s) 
Odour     - Characteristic             
              
 
 
 
Fig 4 Whole plant of Asparagus 
racemosus Willd., 
Fig. 5 Leaves of Asparagus racemosus 
Willd., 
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MICROSCOPY 
The plant bears thin cylindrical climbing stem which bears thin membranous 
scaly leaves and a cluster of curved finger like greenish photosynthetic organs called 
cladodes or phyllodades.  
  In cross section view the phyllodades appear 4 angled or 3 angled with lateral 
projection (Fig 6).The rectangular phyllodade is about 400µm thick. It consists of 
thick and wide radially oblong epidermal cells with fairly prominent cuticle. The 
epidermal cells are 40µm thick. Inner to the epidermis is 2 or 3 layer of circular, 
chlorophyllous palisade cells are seen. Inner to the palisade zone occurs 1 or 2 layer 
of thin walled parenchyma cells. The vascular systems consist of a thick circular 
cylinder of fibres enclosing two small vascular elements (Fig 7& 9).  The vascular 
strands have small cluster of 2 or more wide, angular xylem elements and a thick 
mass of phloem elements (Fig 9).  The bundle sheath fibres are heavily thick walled 
and lignified with narrow lumen. The xylem elements are 30µm in diameter. The 
fibro vascular system is 220µm in diameter. 
The stomata are sunken in the epidermis in section. There are 2 conical 
stomatal ledges on the outer and inner side of the stoma (Fig 8). 
SCALE LEAF 
The scale leaf is thick and spindle shaped in the middle measuring 70µm 
thick. It consists of 3 layer of cell with central core of some 7-8 thick walled cells. 
The marginal part of the scale is uniseriate; the cell being spindle shaped. 
 
 
 
 
 
 
Pharmacognostical Studies 
 
Department of Pharmacognosy, MMC. Page 29 
 
 
 
Fig 6.T.S of Phyllodades entire view. 
(Ep-Epidermis, MT-Mesophyll tissues, Ph-Phloem, X- Xylem) 
 
 
 
Fig 7. T.S of a Phyllodade and scale leaf 
(Ep-Epidermis, PM-Palisade mesophyll, SC-Sclerenchyma, Sc-Scale, SL- Stomatal 
ledge, X- Xylem) 
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Fig 8. T.S of Epidermis of the phyllodade showing sunken stoma  
and stomatal ledges. 
(Ep-Epidermis, PM-Palisade mesophyll, SL- Stomatal ledge, SP-Stomatal pore) 
 
 
Fig 9. T.S of a fibro vascular system with two masses of phloem and xylem. 
(Ph-Phloem, SC-Sclerenchyma, X- Xylem) 
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POWDER MICROSCOPY 
Organoleptic characters 
                                    Color          - Light greenish colour 
                                    Odour        - Characteristic 
                                    Taste           - Bitter   
Microscopical characters 
 The powder of the leaves showed the presence of lignified fibres, epidermis 
with palisade cells and stomata when examined under microscope which are of 
diagnostic importance 
 
 
Fig 10. Lignified fibre Fig 11. Epidermis with palisade cells 
 
Fig 12.  Epidermis with Stomata 
 
Pharmacognostical Studies 
 
Department of Pharmacognosy, MMC. Page 32 
 
 
PHYSICOCHEMICAL PARAMETERS 
 Various physicochemical parameters were evaluated and the observed values 
for the physicochemical constants are given in Table 2. 
                      Table No: 2. Physicochemical Constants 
S. No. Parameters Percentage w/w 
I. ASH VALUES  
1. Total ash 10.47±1.12 
2. Water soluble ash 05.20±0.45 
3. Acid soluble ash 01.34±0.38 
4. Sulphated ash 06.62±0.51 
II. Extractive values  
1. Ethanol soluble extractive 11.42±0.27 
2. Water soluble extractive 38.86±0.47 
3. Ether insoluble non-volatile 21.74±0.35 
4. Ether insoluble volatile 11.23±0.73 
III. LOSS ON DRYING 04.68±0.44 
IV. CRUDE FIBRE CONTENT 51.32±1.42 
V. SWELLING INDEX 03.62±0.76 
VI. FOAMING INDEX Less than 100 
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INORGANIC ELEMENTS AND HEAVY METAL ANALYSIS 
Qualitative estimation of inorganic elements were analyzed and the results 
were tabulated in Table 3. 
                           Table 3. Qualitative estimation of Inorganic elements 
S.No Inorganic elements 
 
Observation 
1 Aluminum  + 
2  Arsenic  - 
3  Calcium  + 
4  Carbonate  - 
5  Chloride  + 
6  Copper  + 
7  Iron - 
8  Lead  - 
9  Magnesium  
 
+ 
10  Mercury  
 
 - 
11  Phosphate  + 
12  Sulphates + 
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Quantitative estimation of Heavy metals by ICP-OES method 
The quantification of the individual heavy metals were done for the powdered 
leaves of Asparagus racemosus Willd., by ICP-OES technique, the following metals 
like arsenic, lead, cadmium and mercury were detected and quantified. The results are 
given in the  Table 4. 
Table 4.Quantitative estimation of Heavy metals 
S.No Element Results (ppm) Specification 
1. Mercury 0.0013 Not more than 0.5ppm 
2. Arsenic 0.0083 Not more than 5.0ppm 
3. Lead Not detected Not more than 10 ppm 
4. Cadmium 0.0037 Not more than 0.3ppm 
 
The above observation showed that the heavy metal is within the limits as per 
WHO standard, so the leaves are safe to consume internally. 
DETERMINATION OF PESTICIDAL RESIDUE BY GC-MS METHOD 
The powdered leaves of Asparagus racemoss Willd., was tested for the 
presence of any pesticide residues by Gas chromatography- Mass spectroscopy 
method using reference standards. The results obtained from the analysis were given 
in Table 5.  
Table 5.  Determination of Pesticidal residues 
 
S.No Pesticide groups Pesticides 
1 Organophosphorus Absent 
2 Carbamates Absent 
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DISCUSSION  
 Pharmacognostical studies play a key factor in establishing the authenticity of 
the plant materials. The botanical identity of the leaf was established by examining its 
morphological, anatomical features as well s the WHO recommended 
physicochemical studies. The results of this standardization may throw immense light 
on the botanical identity of the leaves of Asparagus racemosus which may be useful 
in judging the authenticity of the plant and also to differentiate the leaves from its 
adulterants and substitutes. 
The macroscopy of the leaves were examined. The microcopical characters 
showed the presence of epidermis, mesophyll tissues, phloem, palisade mesophyll, 
sclerenchyma, scale, stomatal ledge, stomatal pore, vascular stands and xylem. 
Powder microscopy showed the presence of lignified fibres, epidermis with 
palisade cells and epidermis with stomata. These features can be employed for inter 
specific identity of the drug. 
             Physicochemical parameters are mainly used in judging the purity and quality 
of the powdered drug. Ash values of a drug give an idea of the earthy matter or 
inorganic elements and other impurities present along with the drug. The ash values of 
a drug are used for detecting low grade product and exhausted drug and hence it 
proves to be important criterion to judge the purity of crude drugs.  A high ash value 
is the indication of substitution, contamination and adulteration.  
The total ash usually consists of carbonate, phosphate and silicates. Total ash 
was found to be 10.47±1.12%w/w. The acid insoluble ash indicates contamination 
with siliceous materials like earth and sand. The value was found to be 
1.34±0.38%w/w. The value of water soluble ash was found to be 5.20±0.45%w/w. 
Sulphated ash is obtained by treatment with dil. sulphuric acid were the oxides are 
converted to sulphates. The value was found to be 6.62±0.51%w/w. 
The parameter which is useful for the prediction of the nature of constituents 
is the extractive value. The alcohol soluble and water soluble extractives were found 
to be 11.42±0.27%w/w and 38.86±0.47%w/w respectively. Ether insoluble non-
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volatile and ether insoluble volatile extractive were found to be 21.74±0.35%w/w and 
11.23±0.73%w/w respectively.  
The alcohol soluble and water soluble extractive value indicates the presence 
of considerable amount of polar compounds. These constants would help to identify 
and to standardize the plant by future researchers. 
The crude fiber content which is used as a distinguishing factor between 
similar drugs was found to be 51.32±1.42%w/w. Loss on drying determines the 
amount of volatile matter of any kind that can be driven off under conditions specified 
and was found to be 04.68±0.44%w/w. The swelling index and foaming index were 
found to be 3.63±0.76ml/gm and less than 100 respectively.   
The qualitative analysis of heavy metals and inorganic elements were carried 
out. The quantitative estimation of heavy metals and pesticide residue were carried 
out and it showed only trace amount of heavy metals (within the limits) when 
compared to beneficial elements and absence of pesticide residue. 
These detailed pharmacognostical studies on leaves of Asparagus racemosus 
provides information on the identification of the drug and also used to differentiate 
the plant from its adulterants and substitutes.  
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8. PHYTOCHEMICAL STUDIES 
            Phytochemical evaluation is used to determine the nature of phytoconstituents 
present in the plant. These constituents are essential for the pharmacological activities 
of the plant. Therefore a complete investigation is required to characterize the 
phytoconstituents qualitatively and quantitatively. 
8.1 MATERIALS AND METHODS 
Preparation of Extracts (53)  
            Extraction is the preliminary step involved in the phytochemical studies. It 
brings out the metabolites into the extracting solvent depends upon its polarity. 
Extraction 
              The shade dried, coarsely powdered leaves of Asparagus racemosus Willd., 
(500gm) was successively extracted with  n-Hexane (60-80°C), chloroform, ethyl 
acetate and ethanol in a soxhlet apparatus. Each extract was concentrated using rotary 
vacuum evaporator. The percentage yield, colour and consistency of these extracts 
were recorded and used for further detailed phytochemical studies. 
Preliminary phytochemical screening (54-56) 
                 The chemical tests for various phytoconstituents in the dried powder and 
extracts of leaves of Asparagus racemosus Willd., were carried out as described 
below and the results were recorded. 
Alkaloids 
Dragendorff’s test  
To the sample, few drops of potassium bismuth iodide solution was added 
(Dragendorff’s reagent), formation of reddish brown color indicates the presence of 
alkaloids.  
Mayer’s test 
 The substance was mixed with little amount of dilute hydrochloric acid and 
Mayer’s reagent and examined for the formation of white precipitate. 
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Wagner’s test 
The test solution was mixed with Wagner’s reagent and examined for the 
formation of reddish brown precipitate. 
Carbohydrates:  
Molischs test 
In a test tube containing sample,  2 ml of distilled water and 2 drops of freshly 
prepared 20% alcoholic solution of alpha naphthol were added and mixed well. 2ml of 
concentrated sulphuric acid along the side of the test tube was added. Formation of 
violet ring at the junction of two layers, which disappears on addition of excess alkali 
solution, indicates the presence of carbohydrates.  
 
Fehling’s test 
The test solution was mixed with Fehling’s A and B, heated and examined for 
the appearance of red coloration for the presence of sugar. 
Glycosides 
Borntrager’s test 
The sample was boiled with 1ml of sulphuric acid in a test tube for five 
minutes. Filtered while hot, cooled and shaken with equal volume of chloroform. The 
lower layer of solvent was separated and shaken with half of its volume of dilute 
ammonia. A rose pink to red colour in the ammonical layer indicates the presence of 
anthroquinone glycosides. 
 
Modified Borntrager’s test  
 The test material was boiled with 2ml of the dilute sulphuric acid. This was 
treated with 2ml of 5% aqueous ferric chloride solution (freshly prepared) for 5 
minutes and shaken with equal volume of chloroform. The lower layer of solvent was 
separated and shaken with half of its volume of dilute ammonia. A rose pink to red 
colour is produced in the ammonical layer. 
 
Phenols  
Small quantity of sample was dissolved in 2 ml of distilled water, added a few 
drops 10% aqueous ferric chloride solution. Formation of blue or green colour 
indicates presence of phenols.  
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Proteins (Biuret’s test)  
To 1 ml of sample solution, 5 to 8 drops of copper sulphate solution (10%) 
was added. Formation of violet colour indicates the presence of proteins.  
 
Saponins  
To 5 ml of sample, added a few drops of sodium bicarbonates solution. Shake 
the mixture vigorously and left for 3 minutes. Formation of honey comb like froth 
indicates the presence of saponins. 
Tannins  
Lead acetate test 
The test solution was mixed with basic lead acetate solution and examined for 
formation of a white precipitate. 
 
Ferric chloride test: 
A few drops of 5% aqueous ferric chloride solution was added to 2ml of an 
aqueous extract of the drug and examined for the appearance of bluish black colour. 
 
Detection of Steroids and Triterpenoids 
Libermann Burchards test 
The sample was treated with few drops of acetic anhydride, boiled and cooled. 
Conc.sulphuric acid was added from the sides of the test tube; brown ring is formed at 
the junction of two layers and upper layer turns green which shows presence of 
steroids and formation of deep red colour indicates presence of tri terpenoids. 
Salkowski test  
 The sample was treated with few drops of conc. sulphuric acid, red colour at 
lower layer indicates the presence of steroids and formation of yellow coloured lower 
layer indicates presence of tri terpenoids. 
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Detection of Flavonoids  
Shinoda’s  test 
To the sample,  few piece of magnesium turnings and conc.HCl was added 
drop wise, pink to crimson red, occasionally green to blue colour appears after few 
minutes indicates the presence of flavonoids. 
 
Alkaline reagent test 
To the test sample few drops of sodium hydroxide solution was added, intense 
yellow colour is formed which turns to colorless on addition of few drops of dilute 
acid indicates the presence of flavonoids. 
 Detection of Gums and Mucilages 
Small quantities of test substances was dissolved in 5 to 10ml of acetic 
anhydride by means of heat, cooled and add 0.05ml of conc. sulphuric acid; it is 
examined for the formation of bright purplish red colour. 
  Detection of fixed oils and fats 
Small quantities of extracts were pressed between two filter papers. An oily 
stain on filter paper indicates the presence of fixed oils and fats. 
QUANTITATIVE ESTIMATION OF PHYTOCONSTITUENTS 
Total phenolic content (Folin – Ciocalteu’s assay) (57) 
                 Total phenolic content of the extracts were determined using Folin –
Ciocalteu’s assay. 0.5ml extracts were mixed with 2.5ml of 10 fold diluted Folin 
Ciocalteu’s reagent and 2.5ml of 7.5% sodium carbonate. After incubation at 40°C for 
30 minutes, the absorbance of the reaction mixtures were measured at 765nm in a 
spectrophotometer. Three replicates were made for each test samples. Gallic acid was 
used as a standard and total phenolic content of the extracts were expressed in mg of 
Gallic acid equivalents (mg GAE/g extract).  
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Total flavanoid content (58) 
                Total flavanoid content was determined by colorimetric method, using 
quercetin as a standard. The test samples were individually dissolved in DMSO. Then 
the sample solution (150 µl) was mixed with 150 µl of 2% aluminium chloride. After 
10min of incubation at ambient temperature, the absorbance of the supernatant was 
measured at 435nm using spectrophotometer. Three replicates were made for each test 
samples. The total flavanoid content was expressed as quercetin equivalent in mg/gm 
of extract (mg QRT/gm extract). 
Total tannin content (59)  
 0.1g of the extracts were transferred to a 100ml flask, 50ml of water was 
added and boiled for 30min. After filtration with cotton filter, filtrate was transferred 
to a 500ml flask and the volumes were made up to the mark with distilled water. 0.5 
ml aliquots were transferred to vials, 1ml of 1% K3Fe (CN)6 and 1 ml of 1% FeCl3 
were added and the volume was made up to 10ml with distilled water. After 5 min 
absorbance was measured at 510nm against a reagent blank spectrophotometer and 
concentration of tannins in the test sample was determined and expressed as mg 
equivalent of tannic acid per gram of sample. 
 
FLUORESCENCE ANALYSIS (60, 61)  
                   Fluorescence analysis was carried out in day light and in UV light. The 
leaf powder was treated with different solvents and the fluorescence was observed in 
day light and in near and far UV light. The extracts were also observed under UV 
light. 
 
CHROMATOGRAPHY (62-64) 
               Chromatographic methods are important analytical tool in the separation, 
identification and estimation of components present in the plant. 
 
Phytochemical Studies 
 
Department of Pharmacognosy, MMC. Page 42 
 
THIN LAYER CHROMATOGRAPHY 
Principle 
              Thin layer chromatography is a technique used for the separation, 
identification of single or mixture of components present in various extracts. It is a 
reliable technique in which solute undergoes distribution between two phases, 
stationary and mobile phase. The separation is mainly based on the differential 
migration that occurs when a solvent flows along the thin layer of stationary phase. 
This may be achieved by partition and adsorption depending on stationary phase used. 
Selection of mobile phase   
            Solvent mixture was selected on the basis of the phytoconstituents present in 
each extracts from the vast analysis, best solvent was selected which showed good 
separation with maximum number of components.   
HPTLC- FINGERPRINT PROFILE (65, 66) 
HPTLC is one of the versatile chromatographic method which helps in the 
identification of compounds and thereby authentication of purity of herbal drugs. The 
time required in this method for the demonstration of most of the characteristic 
constituents of a drug is very quick and short. In addition to qualitative detection, 
HPTLC also provides semi-quantitative information on major active constituents of a 
drug, thus enabling an assessment of drug quality.   
 HPTLC serves as a convenient tool for finding the distribution pattern of 
phyto constituents which is unique to each plant. The fingerprint obtained is suitable 
for monitoring the identity and purity of drugs and for detecting adulteration and 
substitution. HPTLC technique is helpful in order to check the identity, purity and 
standardize the quantity of active principles present in the herbal extract. 
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Instrument Conditions 
Sample used                Ethyl acetate 
Instrument    CAMAG HPTLC 
HPTLC Applicator  CAMAG LINOMAT IV 
HPTLC Scanner  CAMAG TLC SCANNER II 
Sample dilution  100mg of sample extracted with 1ml of Ethyl acetate 
Volume of injection  20µl 
Mobile phase  Toluene:Ethylacetate:Methanol:Formicacid 
(6:3:1:0.2) 
Lambda max   254nm 
Lamp    Deuterium 
Stationary phase        Aluminum coated Silica Gel – MerkF254 
 
Equipment 
 A Camag HPTLC system equipped with a sample applicator Linomat IV, 
Twin trough plate development chamber, TLC Scanner II. 
 
Chromatographic conditions 
 The estimation has been done using the following chromatographic 
conditions. Chromatography was performed on a 10 × 10cm pre-activated HPTLC 
silicagel 60 F254 plate. Samples were applied to the plate as 6mm wide band with an 
automatic TLC applicator Linomat IV with nitrogen flow (CAMAG, Switzerland), 
8mm from the bottom. Densitometric scanning was performed on CAMAG scanner 
II. The plates were pre-washed with solvent ethyl acetate. 
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8.2 RESULTS AND DISCUSSION 
The results of phytochemical studies are as follows, 
Extraction 
The percentage yield of successive extracts of leaves of Asparagus racemosus 
Willd., tabulated in Table 6 
Table 6. Percentage yield of successive extracts of leaves of 
Asparagus racemosus Willd., 
S.No Extract Method   of Extraction 
Physical 
nature Colour 
Percentage 
yield 
(%W/W) 
1 n-Hexane 
Continuous 
extraction 
using Soxhlet 
apparatus 
Semi solid Yellowish brown 3.5% 
2 Chloroform Semi solid Green 4.89% 
3 Ethyl 
acetate Semi solid 
Yellowish 
brown 3.9% 
4 Ethanol Semi solid Brown 4.3% 
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Qualitative phytochemical analysis 
Qualitative phytochemical analysis for the leaf powder and various extracts 
were carried out and the results are tabulated in Table 7. 
Table .7. Preliminary phytochemical screening of powdered leaves and extracts 
 
Note: + ve indicates positive result, whereas – ve indicates negative result 
S.NO Test Powdered leaf 
n-
Hexane Chloroform 
Ethyl 
acetate Ethanol 
1 Alkaloids - - - - - 
2 Carbohydrates + - - - + 
3 Flavanoids + + + + + 
4 Glycosides - - - - - 
5 Phenolic 
compounds + - + + + 
6 Proteins - - - + + 
7 Quinones - - - - - 
8 Saponins + - + + + 
9 Steroids + - + - + 
10 Tannins + - - + + 
11 Terpenoids + - - + - 
12 Volatile oils - - - - - 
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QUANTITATIVE ESTIMATION OF PHYTOCONSTITUENTS 
 The phytoconstituents like tannin, flavanoid and phenolic compounds were 
estimated quantitatively and tabulated in Table 8, 9 and 10. 
 
TOTAL TANNIN CONTENT 
Table 8. Determination of total tannin content 
S.No Concentration of standard 
solution(µg/ml) Absorbance(765nm) 
1. 5 0.10 
2. 10 0.17 
3. 15 0.22 
4. 20 0.31 
5. 25 0.38 
6. Chloroform 0.20±0.019 
7. Ethyl Acetate 0.34±0.038 
8 Ethanol 0.37±0.046 
 
Fig 13 Standard calibration curve for determination of total tannins Content 
y = 0.014x + 0.026
R² = 0.9935
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TOTAL FLAVANOID CONTENT 
Table 9.  Determination of Total Flavanoid content 
S.No Concentration of standard 
solution(µg/ml) Absorbance(765nm) 
1. 10 0.09 
2. 20 0.14 
3. 30 0.20 
4. 40 0.27 
5. 50 0.34 
6. Chloroform 0.17±0.015 
7. Ethyl Acetate 0.19±0.037 
8 Ethanol 0.29±0.028 
 
Fig 14. Standard calibration curve for determination of total Flavanoid Content 
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TOTAL PHENOLIC CONTENT 
Table 10. Determination of Total Phenolic Content 
S.No Concentration of standard 
solution(µg/ml) 
Absorbance(765nm) 
1. 20 0.11 
2. 40 0.17 
3. 60 0.21 
4. 80 0.26 
5. 100 0.33 
6. Chloroform  0.18±0.027 
7. Ethyl acetate  0.22±0.038 
8 Ethanol  0.26±0.034 
 
Fig 15 Calibration curve for determination of total Phenolic content 
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Total  11.  Amount of Tannins, Flavanoid and Phenolic compounds 
 present in extracts 
 
S.No EXTRACTS 
TOTAL 
TANNIN       
CONTENT 
TOTAL 
FLAVANOID       
CONTENT 
TOTAL 
PHENOLIC 
CONTENT 
1. Chloroform 14.73±0.37µg/mg 4.67±0.56 µg/mg 40.31±0.49 µg/mg 
2. Ethyl acetate 16.58±0.45µg/mg 7.98 ±0.48µg/mg 60.85±0.29 µg/mg 
3. Ethanol 19.34±0.33µg/mg 34.44 ±0.62µg/mg 73.78±0.53 µg/mg 
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FLUORESCENCE ANALYSIS 
The Fluorescence analysis of leaf powder and various extracts were carried out and 
given in Table 12 and 13. 
Table 12. Fluorescence characteristic of powdered leaves  
S.NO  TREATMENT  DAY LIGHT  SHORT UV 
(254nm)  
LONG UV 
(366nm)  
1.  Powder  Light green  Green  Dark green  
2.  Powder + water  Yellowish 
green  
Yellowish 
brown  
Green  
3.  Powder + NaoH  Yellowish 
brown  
Dark brown  Dark green  
4.  Powder + HCl  Yellowish 
brown  
Dark brown  Dark green  
5.  Powder + Acetic acid  Dark brown  Brown  Yellowish 
green  
6.  Powder + Alc.KOH  Brown  Brownish green  Green  
7.  Powder + KOH  Light green  Brown  Dark green  
8.  Powder + Sulphuric 
acid  
Dark brown  Dark black  Dark green  
9.  Powder + Nitric acid  Yellowish 
green  
Light brown  Yellowish 
green  
10.  Powder + Iodine  Yellowish 
green  
Brown  Green  
11.  Powder + Feclз  Brown  Dark brown  Green  
12.  Powder +Ammonia  Light green  Greenish black  Dark green  
13.  Ethanol  Greenish 
black  
Brown  Green  
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Table 13. Fluorescence analysis of various extracts  
S.NO Extracts  Day light Short UV Long UV 
1 n-Hexane Yellowish 
brown 
Brown  Dark brown 
2 Chloroform Green  Yellowish 
brown 
Dark green 
3 Ethyl acetate Yellowish 
brown  
Brown  Dark black 
4 Ethanol  Brown  Green  Dark green 
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THIN LAYER CHROMATOGRAPHY OF EXTRACTS 
Thin layer chromatography of n-Hexane, Chloroform, Ethyl acetate and 
Ethanol extracts were carried out and the results are tabulated in Table 14. 
 
Table. 14 Thin layer chromatography studies 
 
                                                                       
 
S.No Extracts Solvent system 
 
No. Of  
Spots 
Rf 
value 
1. 
 
 
n-Hexane Ethyl acetate:  
Chloroform:Ethanol (5:3:2)  
 
3 0.48 
0.51 
0.53  
 
2. 
 
 
Chloroform Ethyl  acetate:  
Chloroform:Ethanol (5:3:2)  
 
4 0.36 
0.39 
0.46 
0.49  
 
3. 
 
 
Ethyl acetate Ethyl  acetate:  chloroform(6:4)  
 
4 0.45 
0.50 
0.52 
0.53  
 
4. 
 
 
Ethanol  Ethyl  acetate:  chloroform(6:4)  3 0.29 
0.31 
0.32  
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Fig 16 TLC of extracts Fig 17 TLC of extracts 
  1. n-hexane extract 
  2. Chloroform extract 
  3. Ethyl acetate extract 
  4. Ethanol extract 
 
  1                  2    3          4  
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HPTLC 
High performance thin layer chromatography (HPTLC) finger printing was 
performed with the ethyl acetate extract of Asparagus racemosus Willd., The 
chromatographic conditions were carried as detailed in material and method of this 
study. There were 9 peaks observed with different Rf values and different heights. 
Percentages of areas were also obtained from the chromatogram.  
 
Table 15 HPTLC profile of ethyl acetate extracts 
S.NO Extract Solvent system Number of 
spots Rf values 
 
 
 
 
Toluene:Ethylacetate:Meth
anol:Formicacid (6:3:1:0.2) 9 
10, 22, 27, 
32, 33, 38, 
63, 70, 73 
 
Fig 18 HPTLC FINGER PRINT FOR ETHYL ACETATE EXTRACT OF       
Asparagus racemosus Willd., 
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DISCUSSION 
 In India most of the traditional knowledge on medical plants is in the oral form 
carried over generations to generations without any standard inventory. Necessary 
steps are needed for proper documentation, systematic regulation and widespread 
application. Since herbal medicines are prepared from materials of plant origin, they 
are prone to contamination, deterioration and variation in composition. Hence, before 
proceeding to clinical studies, scientists need to authenticate plants and also to detect 
their potency. A lot of analytical techniques have been developed for quality control 
of drug from plant origin. 
Therefore it is very important to undertake phytochemical investigation along 
with biological screening to understand therapeutic dynamics of medicinal plant and 
also to develop quality parameter. 
 In this analysis, different polarity of phytoconstituents were sorted out from 
the coarsely powdered leaves of Asparagus racemosus Willd., by using solvents of 
increasing polarity like n-Hexane, Chloroform, Ethyl acetate and Ethanol in soxhlet 
apparatus. Successive extractive values revealed the solubility and polarity particulars 
of the metabolites in the powder. Percentage yield of various extracts were as follows, 
n-hexane (3.5%w/w), chloroform (4.89w/w), ethyl acetate (3.9w/w) and ethanol 
(4.35%w/w). Chloroform extract showed high extractive yield compared to other 
extracts. 
        Qualitative preliminary phytochemical analysis were performed with different 
chemical reagents to detect the phytoconstituent’s nature and their presence in each 
extract and powder. The n-hexane extract showed the presence flavanoids. The 
chloroform extract showed the presence of flavanoids, phenolic compound, saponins 
and steroids. Ethyl acetate extract showed the presence of flavanoids, phenolic 
compounds, proteins, tannins and terpenoids. The ethanolic extract showed the 
presence of carbohydrates, steroids, flavanoids, phenols, proteins, saponnis, and 
tannins. 
The quantitative phytochemical analysis for chloroform, ethyl acetate and 
ethanol extracts were performed.  The total phenolic content was found to be 
40.31±0.49, 60.85±0.29 &73.78±0.53µg/ml%w/w. The total tannin content was found 
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to be 14.73±0.37, 16.58±0.45&19.34±0.33µg/ml%w/w. The total flavanoid content 
was found to be 4.67±0.56, 7.98±0.48&36.44±0.62µg/ml%w/w. 
Fluorescence analysis for leaf powder and extracts were carried which is an 
important qualitative diagnostic tool to detected the presence of chromophore in the 
drug under UV and day light. There was no characteristic florescence observed with 
either in the powder or in the extracts. 
Thin layer chromatographic analysis of all the extracts were carried out using 
different solvent systems. The hexane extract showed 3 spots, where as 4 spots were 
found in chloroform extract. Ethyl acetate extract showed 4 spots and ethanol extract 
showed 3 spots. TLC was performed for the identification of different components in 
the extracts qualitatively. 
HPTLC was done for ethyl acetate extract and the finger print of the extract 
showed 9 spots with the Rf  value of 0.10, 0.22, 0.27, 0.32, 0.33, 0.38, 0.63, 0.70 and 
0.73. 
Since secondary metabolites are responsible for the therapeutic activity, this 
study will be helpful in the selection of extract for pharmacological activity. 
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9. SELECTION OF ACTIVE EXTRACT 
INVITRO ANTICANCER ACTIVITY 
9.1 MATERIALS AND METHOD  
Method : MTT Assay  
Extracts used: Chloroform, ethyl acetate and ethanol extracts 
Cell line used 
The human cervical cancer cell line (HeLa) was obtained from National 
Centre for Cell Science (NCCS), Pune and grown in Eagles Minimum Essential 
Medium containing 10% fetal bovine serum (FBS). The cells were maintained at 
370C, 5% CO2, 95% air and 100% relative humidity. Maintenance cultures were 
passaged weekly and the culture medium was changed twice a week. 
Cell treatment procedure 
The monolayer cells were binding with trypsin-ethylen diaminetetraacetic acid 
(EDTA) to make single cell suspensions and viable cells were counted using a 
heamocytometer and diluted with medium containing 5% FBS to give final density of 
1x105 cells/ml. One hundred microlitres per well of cell suspension were seeded into 
96-well plates at plating density of 10,000 cells/well and incubated to allow for cell 
attachment at 370C, 5% CO2, 95% air and 100% relative humidity. After 24 h the cells 
were treated with serial concentrations of the test samples. They were initially 
dissolved in dimethylsulfoxide (DMSO) and an aliquot of the sample solution was 
diluted to twice the desired final maximum test concentration with serum free 
medium. Additional four serial dilutions were made to provide a total of five sample 
concentrations. Aliquots of 100 µl of these different sample dilutions were added to 
the appropriate wells already containing 100 µl of medium, resulting in the required 
final sample concentrations. Following sample addition, the plates were incubated for 
an additional 48 h at 370C, 5% CO2, 95% air and 100% relative humidity(67). The 
medium containing without samples were served as control and triplicate was 
maintained for all concentrations.  
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MTT assay 
Principle 
This colorimetric asay is based on the capacity of a mitochondrial enzyme in 
living cells, succinate-dehydrogenase, cleaves the tetrazolium ring, converting the 3-
[4,5-dimethylthiazol-2-yl]2,5-diphenyltetrazolium bromide (MTT) into a insoluble 
purple formazan product which is measured spectrophotometricallly. Only viable cells 
with active mitochondria reduces the MTT, the amount of formazan produced is 
directly proportional to the number of viable cells(68). 
Procedure 
After 48 h of incubation, 15µl of MTT (5mg/ml) in phosphate buffered saline 
(PBS) was added to each well and incubated at 370C for 4h. The medium with MTT 
was then flicked off and the formed formazan crystals were solubilized in 100µl of 
DMSO and then measured the absorbance at 570 nm using 96 well plate counter (69). 
The % cell inhibition was determined using the following formula.  
% Cell Inhibition = 100- Abs (sample)/Abs (control) x100.  
Nonlinear regression graph was plotted between % Cell inhibition and Log 
concentration and IC50 was determined using GraphPad Prism software. 
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9.2 RESULTS AND DISCUSSION 
The invitro anticancer activity of the chloroform, ethyl acetate and ethanol 
extracts were given in Table 16, 17 and 18. 
Table  16. MTT Assay of Chloroform extract 
Plant extract Conc.µg/ml Absorbance % inhibition IC50 µg/ml R
2 
Chloroform  
exrtract of 
Asparagus 
racemosusus 
Willd., 
18.75 0.4053 2.1721 
62.587µg/ml 0.9993 
37.50 0.3633 12.3089 
75 0.1376 66.7739 
150 0.2366 94.2880 
300 0 100 
 
 
Fig 19 DOSE RESPONSE CURVE OF CHLOROFORM EXTRACT OF 
Asparagus racemosus FOR HELA CELL LINE BY MTT ASSAY 
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Table  17. MTT Assay  of Ethyl acetate extract 
Plant extract Conc.µg/ml Absorbance % inhibition IC50 µg/ml R
2 
Ethyl acetate 
exrtract of 
Asparagus 
racemosusus 
Willd., 
18.75 0.4133 0.2413 
87.837µg/ml 0.9999 
37.50 0.4073 1.6894 
75 0.2930 29.2839 
150 0.0193 95.3338 
300 0.0036 99.1150 
 
Fig 20  DOSE RESPONSE CURVE OF ETHYL ACETATE OF Asparagus 
racemosus FOR HELA CELL LINE BY MTT ASSAY 
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Table  18. MTT Assay of Ethanol extract 
Plant extract Conc.µg/ml Absorbance % inhibition IC50 µg/ml R
2 
Ethanol 
extract of 
Asparagus 
racemosus 
Willd., 
18.75 0.4110 0.8045 
297.7µg/ml 0.9953 
37.50 0.40833 1.4481 
75 0.4016 3.0571 
150 0.3836 7.1600 
300 0.2040 50.764 
 
Fig 21 DOSE RESPONSE CURVE OF ETHANOL OF Asparagus racemosus 
FOR HELA CELL LINE BY MTT ASSAY 
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DISCUSSION 
 The invitro anticancer study for chloroform, ethyl acetate and ethanol extracts 
were carried out by MTT assay. The extracts were screened for its cytotoxicity against 
HeLa cell line at different concentration to determine the IC50 value. 
The results are tabulated and graphically represented. The percentage growth 
inhibition was found to be increased with the increasing concentration of test 
compound. The IC50 value of Chloroform, Ethyl acetate and Ethanol extracts on the 
HeLa cell line were found to be 62.587, 87.837, 297.9 µg/ml and R2 values were 
0.9993, 0.9999, 0.9953 respectively. The chloroform and ethyl acetate extract showed 
significant invitro anticancer activity against HeLa cell line when compared to the 
ethanol which was taken for further invivo anticancer studies. 
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10. PHARMACOLOGICAL STUDIES 
10.1 ACUTE TOXICITY STUDY (70 , 71)  
10.1.1  MATERIALS AND METHOD 
 Acute toxicity study was designed as per the OECD guidelines 423. (Acute 
toxic class method).  
Principles and purposes  
Acute toxicity testing determines the toxicity of a chemical or drug substances 
after single administration. The main purpose of acute toxicity study is to evaluate the 
degree of toxicity in a quantitative and qualitative manner.  
 
The method of determination has changed in the last three decade mainly for 
animal welfare reasons producing mortality in animals in order to determine LD 50 is 
no longer the main purpose of acute toxicity testing. The test is based on stepwise 
procedure with use of minimum number of animals per step. Sufficient information is 
obtained on the acute toxicity of the substance to enable its classification. The 
substance is administered orally to a group of experimental animals at one of the 
defined dose. The substance is tested using a stepwise procedure, each step using 
three animals or a single sex (normally females). Absence or presence of compound 
related mortality of the animals dosed at one step will determine the next step i.e.  
 
• No further testing is needed  
• Dosing of three additional animals with the same dose  
• Dosing of three additional animals with the next higher (or) the next 
lower dose levels 
 
Selection of dose level and administration of dose 
 The traditional herbal medicine the mortality was unlikely at the highest 
starting dose level (2000mg/Kg body weight). Hence a limit test at dose level of 
2000mg/Kg body weight was conducted in all three animals. 
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Experimental animals  
Healthy Swiss Albino Mice either sex weighing between 20-25g were selected 
for the study. For all the three animals water was provided ad libitum and food was 
withheld overnight prior to dosing. 
 
Observation 
The animals were observed individually after dosing once during the first 30 
minutes, periodically for the first 24 hours, with special attention given during the 
first 4 hours, and daily thereafter for a total of 14 days. The following clinical 
observation were made and recorded.  
 
Toxic signs 
All mice were observed for any toxic signs. 
  
Body weight  
Individual body weight was recorded for all the animals.  
 
Cage side observation  
The faeces colour, faeces consistency, change in skin and fur, eyes, mucus 
membrane (nasal) of the animals were observed.  
 
Physical Examination 
 Physical observation included changes in respiratory system (rate), 
cardiovascular system (heart rate), autonomic nervous system (salivation, lacrimation, 
piloerection, urinary incontinence and defecation), central nervous system 
(drowsiness, convulsions, motor activity, writhing, motor in coordination, righting 
reflex, pinna reflex, corneal reflex and tremors were recorded. 
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10.1.2. RESULTS AND DISCUSSION 
 Behavioural and physical observation of the animals treated with ethyl acetate 
and chloroform extracts was noted of and tabulated in Table 19. 
Table  19. Acute toxicity studies 
 
 The acute toxicity studies were done by OECD guidelines 423. No mortality 
was observed following the oral administration of leaves extracts even with the 
highest dose 2000mg/kg body weight. So, 1/5th of this dose (400mg/kg) was selected 
for the invivo anticancer activity. 
OBSERVATION  30mins  4 hrs  24 hrs  14th day  
Body weight  No change  No change  No change  No change  
Preterminal deaths  Absent  Absent  Absent  Absent  
Cage side observation  Normal  Normal  Normal  Normal  
Motor activity  Normal  Normal  Normal  Normal  
Convulsions  Absent  Absent  Absent  Absent  
Piloerection  Absent  Absent  Absent  Absent  
Righting reflex  Present  Present  Present  Present  
Lacrimation  Normal  Normal  Normal  Normal  
Salivation  Normal  Normal  Normal  Normal  
Respiration  Normal  Normal  Normal  Normal  
Skin color  Normal  Normal  Normal  Normal  
Diarrhoea  Absent  Absent  Absent  Absent  
Loss of corneal reflex  Normal  Normal  Normal  Normal  
Loss of pinnal reflex  Normal  Normal  Normal  Normal  
Grooming  Absent  Absent  Absent  Absent  
Sedation  Normal  Normal  Normal  Normal  
Excitation  Normal  Normal  Normal  Normal  
Aggression  Normal  Normal  Normal  Normal  
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10.2 INVIVO ANTICANCER ACTIVITY 
EHRLICH’S ASCITES CARCINOMA (72, 73) 
Ehrlich’s Ascites Carcinoma (EAC) used in the present investigation has been 
maintained in the ascitic form in Albino Swiss mice by serial intraperitoneal 
transplantation. The tumor originally appeared in the mammary gland of a white 
mouse in 1907. The discovery was credited to Dr. P.Ehrlich. An ascitic form of this 
tumor was produced subcutaneously by Lowenthal and Jahn by intraperitoneal 
injection of tumor cell suspension. The ascitic fluid contained about 2.5-10 x 107 
tumor cells/ml at day 10 after transplantation (i.p.) of 1x106 cells. The host animals 
survived approximately 3 weeks after tumor implantation.   
10.2.1.  MATERIALS AND METHOD 
Materials   
EAC cell line, heamocytometer, hemoglobinometer, Thoma pipettes, 
tuberculin syringes, needle, sterile scalpel, forceps and scissors. 
Extracts used  
Chloroform and ethyl acetate extracts 
Cell line  
Ehrlich Ascites Carcinoma (EAC) cells were obtained through the courtesy of 
National Cancer Institute, Chennai, India. The EAC cells were maintained in Swiss 
Albino mice, by intraperitoneal (i.p.) transplantation of every 9 days(74). The ascitic 
fluid was collected by syringe and the tumor cell count was performed in a Neubauer 
hemocytometer and 2 x 107 cells/per ml was obtained by dilution with normal saline 
(75)
. EAC cells 9 days old were used for the screening study. 
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Animals 
Swiss Albino mice of either sex of 6-8 weeks age and weighing 20 ± 2 g were 
used throughout the study. The animals were kept in polypropylene cages on sawdust 
beds, which were changed twice a week and maintained under standard laboratory 
conditions (temperature 25±20C) with dark/ light cycle (14/10 hrs). They were 
allowed free access to food and tap water ad libitum. The mice were acclimatized to 
laboratory condition for 1 week before the commencement of experiment. 
 Table 20. Grouping of animals 
Treatment schedule  
Swiss Albino mice were weighed (20 ± 2 g) and divided into 4 groups (n=10) 
and given food and water ad libitum. EAC cells (2x106 cells/mouse) were injected 
intraperitoneally to each mouse of each group. This was taken as day 0. On the first 
day groups II and III were administered with chloroform and ethyl acetate extracts 
orally and group IV received standard drug 5-fluorouracil (20mg/kg) for 14 
subsequent days. On 15th day, 18 hr after the last dose and 24 hr fasting five mice 
were sacrificed from each group and the rest of the animal of each group were kept to 
observe the life span of the tumor hosts.  
The groups and the design of the experiment were as follows:  
Group I  : EAC (2x106 cells /mice) + Normal saline (5ml of 0.9% NaCl / kg)  
Group II  : EAC (2x106 cells /mice) +Chloroform Extract (400 mg/ kg/p.o) 
Group III  : EAC (2x106 cells /mice) + Ethyl acetate extract(400 mg/ kg/p.o) 
Group IV : EAC (2x106 cells/mice) + 5-fluorouracil (20mg/kg/i.p) 
S.No Groups  Description  Number of 
animals 
1 Group I Disease control 10 
2 Group II Chloroform extract 
(400mg/kg /p.o) 
10 
3 Group III Ethyl acetate extract 
(400mg/kg/ p.o) 
10 
4 Group IV 5-fluorouracil(20mg/kg/i.p) 10 
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Ehrlich ascitic carcinoma tumor growth response 
The ascitic fluid was completely harvested from each animal in all the groups 
and ascitic tumor volume, viable and nonviable tumor cell count by using 0.4% 
tryphan blue dye exclusion assay method was performed. 
Tumor volume  
The mice were dissected and the ascitic fluid was collected from the peritoneal 
cavity. The volume was measured by taking it in a graduated centrifuge tube and 
packed cell volume determined by centrifuging at 1000g for 5 min. 
Viable and nonviable tumor cell count 
 The cells were then stained with trypan blue dye (0.4% in normal saline). The 
cells that did not take up the dye were viable and those that took the stain were 
nonviable. These viable and nonviable cells were counted. 
   
                            No. of cells x Dilution  
Cell count =     ------------------------------------ 
    Area x Thickness of liquid film 
 Survival time 
Mean survival time (MST), percentage of mean survival time (%MST) and 
percentage increased life span (% ILS) was evaluated to all the groups. MST of each 
group animals were monitored by recording the mortality daily and calculated using 
the following equation(76). 
                                                Day of 1st death + Day of Last death  
               Mean survival time = ------------------------------------------------ 
                                     2 
The results are expressed as percentage of mean survival time of treated 
animals over mean survival time of the control group (Vs control, T/C %). The 
percentage of lifespan (ILS %) was calculated according to the formula:  
ILS%= (T-C) / C X 100 
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Where T represents mean survival time of treated animals; C represents mean 
survival time of control animals. By National Cancer Institute criteria, T/C exceeding 
125% and ILS exceeding 25% indicate that the drug has significant antitumor 
activity(77). 
Heamatological profiles (78, 79) 
At the end of experimental period, half of the mice were killed the next day 
after an overnight fasting by decapitation. Blood was collected retro orbital fluxes and 
used for  estimation  of  heamoglobin  (Hb)  content,  red  blood  cell  count  (RBC),  
white  blood  cell count (WBC) and WBC differential count. 
Heamoglobin estimation 
0.1-Ml of heparinized blood was taken in Sahli’s Heamoglobinometer and 
diluted with 0.1N HCl until the color matched with standard. The reading was then 
taken from the graduated cylinder and expressed as gm/100ml of blood. 
Total count of erythrocytes 
The blood sample was diluted (1:200) with diluting fluid by using Thoma 
pipette.  
The diluting fluid is composed of  
Neutral Glycerine   20.0ml 
Sodium Sulphate   8.0g 
Sodium Chloride   1.0g 
Methyl Violet    25.0mg 
Distilled water    160.0ml 
After vigorous mixing, a drop of resultant mixture was discharged under the 
cover glass of Neubauer heamocytometer and the corpuscles were allowed to settle 
for 3 minutes. The number of erythrocytes in 80 small squares were counted under 
light microscope. The number of cells in 1µl of undiluted blood was calculated by: 
RBC count/ µl = Number of cells in 80 small squares x (1.0/0.02) x 200  
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Total count of leukocytes  
Blood was diluted 1:20 with a diluting fluid containing 3% acetic acid and a 
few drops of aqueous solution of methylene blue. The Neubauer hemocytometer was 
filled similarly with the mixture as in case of erythrocyte counting and the number of 
cells in four corner blocks (each block subdivided into 16 squares) were counted. The 
total leukocyte count per µl of blood was calculated from multiplying the average 
number of cells in four blocks by 200. 
Differential count of leukocytes 
Freshly drawn blood without anticoagulant was used to prepare blood films on 
perfectly clean grease free slides. 
The smears were air dried and stained with Leishman’s stain at pH: 6.4-6.8 
(One gram of dry Leishman’s-eosin- methylene blue was placed in a clean, dry, dark 
bottle and 500 ml of acetone free methyl alcohol was added. The mixture was filtered, 
kept in a dark place for at least a week and shaken daily for five minutes. A buffer 
solution of pH: 6.4 was used during staining to maintain the pH of the stain around 
(6.4-6.8). The blood film was covered with undiluted stain and left for one minute. 
a) The stain was washed with two volumes of buffer solution until a metallic scum 
appears. 
b) The mixture was allowed to remain for 8-10 min; the slides were then flooded with 
tap water and were washed. The slides were air dried and observed under oil 
immersion objective of a light microscope. The cells were identified and counted 
according to their nuclear-cytoplasmic characteristics. The percentage distribution of 
each type of white blood cell (WBC) was calculated after counting at least 100 
leukocytes. 
Statistical analysis 
 The experimental data were expressed as mean±SEM. The data were analyzed 
using ANOVA and Dunett’s test. The results were considered statistically 
significance if p<0.05. 
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10.2.2 RESULTS AND DISCUSSION 
 The invivo anticancer activity for chlorofrom and ethyl aceata etract were carreied out and tabullated in Table 21 and 22. 
Table 21.Effect of Chloroform and Ethyl acetate extract of Asparagus racemosus on the tumor growth parameter 
 
Groups Body weight (gm) 
Mean survival 
time (days) %ILS 
Tumor 
volume (Ml) 
Viable cell 
count (107 
cells/ml) 
Nonviable cell 
count (107 
cells/ml) 
I Group 
EAC control 
25.35±0.31 18.64±1.25 - 6.92±0.13 11.64±0.09* 3.23±0.73 
Group II EAC+ (Chloroform 
Extract 400 mg/kg.b.w) 25.35±0.31* 23.53±0.40* 26.23* 6.44±0.15* 6.25±0.03* 0.77±0.02* 
Group III 
EAC+(Ethylacetate Eaxtract 
400 mg/kg.b.w) 
22.57±0.43* 27.34±0.32* 46.67* 5.47±0.16* 4.21±0.03* 1.55±0.10* 
Group IV EAC+(5-FU, 
20mg/kg.b.w) 21.34±0.12* 34.9 ± 0.41* 87.32* 3.62±0.14* 3.34±0.02* 6.91±0.05* 
 
Values are as mean± SEM. Number of mice in each groups (n=10),*P<0.05 as compared with group I, *P <0.05 considered as significant. 
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Table  22. Effect of Chloroform and Ethyl acetate extract of Asparagus racemosus on heamatological parameters 
 
Groups Heamoglobin (g/dl) 
RBC 
(Count x 108) 
WBC 
(Count x 108) 
Lymphocyte 
(%)b Monocyte (%)
b
 
Granulocyte 
(%)b 
I Group 
EAC control 
10.40±1.23 3.26±0.58 5.31±0.30 40.72±0.82 2.32±0.15 26.17±0.20 
Group II EAC+ 
(Chloroform Extract 
400 mg/kg.b.w) 
10.92±0.82*** 3.76±0.03*** 8.21±0.58*** 63.05±0.46 *** 16.61±0.21*** 4.62±0.18 *** 
Group III 
EAC+(Ethylacetate 
Eaxtract 400 
mg/kg.b.w) 
11.97±0.17** 6.10±0.26 ** 9.37±0.20 ** 76.47±0.61** 5.05±0.33 ** 17.95±0.21* * 
Group IV EAC+(5-
FU, 20mg/kg.b.w) 12.52±0.31** 5.62±0.31** 11.75±0.17** 77.60±0.50** 4.20±0.27** 17.37±0.30** 
 
Vales are expressed as means± SEM. Number of mice in each groups (n=10), ***P<0.001, **P<0.01 when compared to EAC control group, 
P<0.05 is considered as significant 
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Fig 22  GRAPHICAL REPRESENTATION OF BODY WEIGHT(gm) 
 
 
Fig  23 GRAPHICAL REPRESENTATION OF MEAN SURVIVIAL 
TIME(days) 
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Fig  24  GRAPHICAL REPRESENTATION OF % INCREASE IN LIFE SPAN 
 
 
Fig 25  GRAPHICAL REPRESENTATION OF HEAMOGLOBIN(%) 
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Fig 26 GRAPHICAL REPRESENTATION OF RBC COUNT (1×106 cells/mm3) 
 
 
Fig 27 GRAPHICAL REPRESENTATION OF WBC COUNT (1×103 cells/mm3) 
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Fig 28 GRAPHICAL REPRESENTATION OF  CELL VOLUME(ml)  
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10.2.2  RESULTS AND DISCUSSION 
The result suggests that the chloroform and ethyl acetate extract of Asparagus 
racemosus showed significant antitumor activity in EAC bearing mice. The effect of 
A. racemosus extracts at the dose of 400mg/kg on biological parameters are discussed 
below.  
 
Effect of Asparagus racemosus on mean survival time and tumor growth 
The present investigation indicates that the Chloroform and ethyl acetate 
showed significant antitumor activity in EAC bearing mice. The effects of chloroform 
and ethyl acetate (400 mg/kg) at on the body weight, tumor volume, viable and 
nonviable cell count, survival time and ILS, were shown in Table 21 and 22. 
Administration of chloroform and ethyl acetate extract reduces the tumor volume, 
packed cell volume and viable tumor cell count when compared to EAC control mice. 
In EAC control mice the mean survival time was 18.64±1.25 days. Whereas, it was 
significantly increased when treated with chloroform, ethyl acetate and standard drug 
(23.53±0.40, 27.34±0.32, 34.9 ± 0.41days) respectively.  
 
The increase in the life span was observed with the mice treated with 
chloroform, ethyl acetate and 5-fluorouracil (P<0.01) as compared to the control 
group.  
 
Effect on heamatological parameters 
 The heamoglobin content in the EAC control mice (9.8g %) was significantly 
decreased where as in extract treated group the percentage of heamoglobin was 
increased to10.92±0.82 g % and 11.97±0.17g %. Moderate changes in the RBC count 
were also observed in the extract treated mice. The total WBC counts were 
significantly higher in the EAC control mice whereas, extract treated mice shows 
significant reduction in the WBC counts as compared to that of control mice. The 
differential leukocyte count, the percentage of neutrophils was increased while the 
lymphocyte count was decreased in the extract treated mice when compared with 
EAC control mice. 
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 The present study was carried out to evaluate the anticancer effect of 
Asparagus racemosus on EAC bearing mice. The ethyl acetate extract of Asparagus 
racemosus showed significant anticancer activity when compared to chloroform 
extract against the transplantable tumor. The reliable criteria for judging the value of 
any anticancer drug are the prolongation of life span of animals. A reduction in the 
number of ascitic tumor cells may indicate either an effect on peritoneal macrophages 
or other components of the immune system, therefore increasing their capacity of 
killing the tumor cells, or a direct effect on tumor cell growth.  The ethyl acetate 
extract of leaves of Asparagus racemosus inhibited significantly the tumor volume, 
viable cell count and enhancement in survival time of EAC bearing mice and thereby 
acts as anti-neoplastic agent.  
 
 Myelo supression is a frequent and major complication of cancer 
chemotherapy. The treated and subsequent tumor inhibition resulted in appreciable 
improvements in heamoglobin content, RBC and WBC counts. These observations 
assume great significance, as anemia is a common complication in cancer and the 
situation aggravates further during chemotherapy since a majority of antineoplastic 
agents exert suppressive effects on erythropoiesis and thereby limiting the use of these 
drugs. The improvement in heamatological profile of the tumor bearing mice 
following the treatment with extract could be due to the action of the different 
phytoconstituents present in the extract. 
 
 
Isolation and Identification of Rutin 
 
Department of Pharmacognosy, MMC. Page 79 
 
 
11. ISOLATION AND IDENTIFICATION OF RUTIN 
 
Since rutin was found to posses anticancer activity an attempt was made to 
isolate and identify the rutin from the Ethyl acetate extract of Asparagus racemosus. 
Rutin, also called as rutoside, quercetin-3-rtinoside and sophorin, is the glycoside 
between the floavonol quercetin and the disaccharide rutinose (α-L-rhamnopyranosyl-
(1→6))-β-D glucopyranose). Rutin is that the rhamno glucoside of the flavonoid 
quercetin, and located in several plants and used for treatment of various diseases 
associated with the vascular. The molecular formula C27H30O16(80) 
 
Occurrences   
Asparagus leaves and flower have been found to contain more rutin (about 
2.5% dry weight)(82). Rutin is one of the phenolic compounds found in the invasive 
plant species Carpobrotus edulis. Rutin is a citrus flavonoid glycoside found in many 
plants including buckwheat, the leaves and petioles of Rheum species Rutin is also 
found in the fruit of the Fevadanta tree, fruits and flowers of the pagoda tree, fruits 
and fruit rinds (especially the citrus fruits orange, grape fruit, lemon and lime) and 
apple; berries such as mulberry, ash tree fruits, aronia berries and cranberries (84). 
 
Chemical relatives   
Rutin (quercetin tutinoside), like quercetin,is a glycosides of the flavonoid 
quercetin. As such, the chemical structure of both are very similar, with the difference 
existing in the hydroxyl functional group. Both quercetin and rutin are used in many 
countries as medication for blood vessel protection, and are ingredients of numerous 
multivitamin preparation and herbal remedies (83, 84). 
 
Fig 29 Structure of Rutin 
Isolation and Identification of Rutin 
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Uses of rutin  
Anti-inflammatory, antioxidants inhibit platelet aggregation and decrease the 
capillary permeability, making the blood thinner and improving the circulation, 
strengtheners the capillaries and can be used to treat hemorrhoids, varicose vein and 
unpleasant- looking venous oedema of the legs, lowered LDL cholesterol and the risk 
of antherosclerosis and heart beats(85). Rutin having  a VEGE inhibitor (angiogenesis 
inhibitor) that can help  to prevent some  cancer. Moreover rutin has been used 
clinically as a therapeutic medicine because it’s strong antioxidant properties(86). So 
the present study is aimed to isolate and study the anticancer activity of rutin present 
in Asparagus racemosus. 
 
11.1 MATERIALS AND METHOD 
           
          Extract used             : Ethyl acetate extract  
    Method     : Partition separation 
        
Procedure (87) 
To 3gm of extract, 25 ml of H2O was added and extracted with petroleum 
ether (50ml x 3), then with chloroform (50 ml x 3). After extraction, the aqueous layer 
was collected and left to stand during a cold place for 72 hours; a yellow precipitate 
separated out of the solution. The precipitate was filtered and washed with a 
combination of chloroform: ethyl acetate: ethanol (50:25:25). The un-dissolved a part 
of the precipitate was dissolved in hot methanol and filtered, the filtrate was 
evaporated to dryness. The yellow powder of  Rutin obtained.  
Identification of Isolated Rutin  
Melting point 
 Melting point of the isolated compound was determined by using melting 
point apparatus.  
Chemical test 
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To the isolated compound copper acetate was added, formation of emerald 
green colour indicates the presence of rutin. 
TLC  
 The isolated compound was subjected in to TLC studies 
Stationary phase: Pre-coated aluminum sheet with silica gel G 
Mobile phases: Butanol: acetic acid: water (5:3:5) 
SPECTRAL STUDIES 
 The isolated compound was subjected to IR spectral analysis 
INFRA-RED SPECTROSCOPY 
 It is the absorption measurement of different IR frequencies by a sample 
positioned in the path of an IR beam. It is carried out for the determination of 
chemical functional group in the sample. The commonly used sampling techniques for 
solid include pressed pellet technique and for liquid sample Nujol mull technique. The 
most useful IR region lies was between 4000-670 cm-1. Vibration (stretching and 
bending) that cause changes in dipole moment and bond length when IR radiation of 
suitable frequency is applied, then the vibration are infra-red active. 
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11.2 RESULTS AND DISCUSSION 
Physical and chemical properties of isolated compound 
Colour   Greenish-yellow 
Nature   Powder 
Melting point                  188- 190 0C 
Solubility                    Soluble in water  
Chemical test          Emerald green colour was obtained with  
    copper acetate test its indicates  presence of  
    Rutin 
TLC solvent system         Butanol: acetic acid: water (5:3:5) 
             Rf  value                           0.82 
 
Fig 30 TLC Rutin 
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IR SPECTROSCOPY  
IR Vcm-1 :  KBr disk method 
IR SPECTRUM 
 
Fig 31 IR spectrum of isolated Rutin  
 
 
Fig 32  IR spectum of  previously isolated Rutin 
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Table 23 IR Spectra of isolated compound 
S.NO Obervation Observed wave number (cm-1) 
1 OH streching 3363.45 
2 C-H  streching Alkene 3085.7 
3 C-H streching Alkane 2935.4 
4 C-H streching  Aldehyde 2726.45 
5 C=C streching Alkene 1648.4, 1609.4 
6 C=C  streching Alkene 1538.34 
7 C-H bending 1488.9 
 
 The ethyl acetate extract was used for the isolation of Rutin. The compound 
was isolated and identified by melting point, chemical test, TLC and IR spectrum. The 
results observed matches with the previously isolated rutin. Further study is focused 
on other spectral analysis and  anticancer activity of Rutin. 
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12. SUMMARY AND CONCLUSION 
Cancer is one of the leading causes of death worldwide. Currently available 
allopathic drugs for treating cancer causes number of side effects hence, people are 
now looking towards the herbal medicine. This paved a vital necessity for finding 
natural anticancer drug from herbal source. Asparagus racemosus Willd., is one such 
plant which is traditionally used in the treatment of cancer was selected for the 
present study.  
The literature survey showed only scrappy information on the leaves of this 
plant. With this scanty of information on the leaves, consistent expectation of 
unexplored phytochemical profile and pharmacological efficacy forms the rationale 
for the study. 
 
Pharmacognostical studies  
A perusal of literature showed paucity of pharmacognostical information on 
the leaves of this plant. Hence, it was carried out and reported for the first time.  
 
In pharmacognostical studies macroscopy, microscopy, determination of 
physicochemical constants, analysis of inorganic elements, heavy metals and pesticide 
residue of the leaves were carried out.  
Macroscopical study showed that the leaves are pine needle (phylloclades) 
shaped, sweet and bitter taste and dark green in colour. The various distinguishing 
features of leaves observed through anatomical studies were,  
 Phyllodades  3-4 angled with lateral projections 
 Radially oblong epidermal cells with prominent cuticle 
 Circular chlorophyllous palisade cells 
 Vascular strands with angular xylem and thick mass of phloem 
elements  
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The microscopical analysis of powder showed the presence of lignified fibres, 
epidermis with palisade cells and stomata.   
Various physicochemical constants such as ash values, extractive values, loss 
on drying, crude fibre content, swelling index and foaming index were carried out. 
These values will help in confirming the identity and purity of the plant. Any 
significant deviation in the percentage of any parameters reported in this work may 
indicate adulteration or substitution in the drug. 
 
Qualitative estimation of inorganic elements, quantitative estimation of heavy 
metals and pesticide residue were carried out and it showed only trace amount of 
heavy metals (within the limits) and absence of pesticide residue. 
 These pharmacognostical details observed from the present study might offer 
reliable clues for the correct identification of the leaves of this plant in crude as well 
as fragmentary form and also ensures its differentiation from its substitutes and 
adulterants. This is first report on the pharmacognostical standardization on the leaves 
of Asparagus racemosus Willd., 
Phytochemical studies 
Phytochemical evaluation deals with chemical analysis of the extracts used for 
pharmacological screening.  
 
The successive solvent extraction was carried out with solvents like n-Hexane, 
chloroform, ethyl acetate and ethanol.  Chloroform extract showed more percentage 
yield when compared to other extracts. Qualitative preliminary phytochemical 
analysis was aided in identifying the phytoconstituents present in different extracts. 
Quantitative estimation of flavanoid, tannin and phenolic content were carried out, for 
the extracts. Fluorescence analysis was carried out, to detect the fluorescent 
chromophores present in the powdered drug as well as in the extracts. No 
fluorescence was observed in powder and the extracts. 
 
Thin layer chromatography for the extracts was performed to identify the 
single or mixture of constituents in the extract. High Performance Thin Layer 
Chromatography- Finger print profile was carried out to detect the number of 
constituents present in the ethyl acetate extract. 
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Invitro studies 
 The therapeutically active extract to carry out the invivo anticancer activity 
was selected based on invitro anticancer activity. The chloroform, ethyl acetate and 
ethanol extracts were subjected to invitro anticancer studies using HeLa cells line by 
MTT assay. Chloroform and ethyl acetate extracts showed significant anticancer 
activity by MTT assay and these two extracts were selected for invivo anticancer 
studies. 
 
Acute toxicity studies 
Acute toxicity study was carried out for chloroform and ethyl acetate extracts 
according to OECD guidelines 423. The extracts are non-toxic up to 2000mg/kg body 
weight indicating the safety of the extracts. 
 
Invivo anticancer studies 
Invivo anticancer activity of chloroform and ethyl acetate extracts were carried 
out on Ehrlich’s Ascites Carcinoma (EAC) bearing mice. The ethyl acetate extract 
showed significant anticancer activity at the dose of 400mg/kg body weight when 
compared to chloroform extract and the effects were comparable with the standard 
drug.  
 Since, rutin was found to possess anticancer activity, an attempt was made to 
isolate rutin by partition separation method. The isolated compound was subjected to 
melting point, chemical test, TLC and IR spectroscopic studies. 
 From the above mentioned studies, it can be concluded that the 
pharmacognostical standards generated for the leaves will be useful for the proper 
identification of the plant. With the support of phytochemical and invitro cytotoxic 
activity the chloroform and ethyl acetate extracts were selected and subjected to 
invivo anticancer activity. The ethyl acetate extract at the dose level of 400mg/kg 
showed significant anticancer activity. Further studies are focused on detailed spectral 
analysis of isolated rutin and isolation of other phytoconstituents which is responsible 
for anticancer activity of the leaves. 
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